Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-15

Clinical Trial Update: Study on Clinical Effectiveness of L-Oxiracetam Injection [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating the clinical effectiveness of L-Oxiracetam Injection in craniocerebral injury has an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-Oxiracetam Injection (L-Oxiracetam)

Snippet

Sponsor: Nanjing Yoko Biomedical Co., Ltd. | Conditions: Craniocerebral Injury | Phase 3 | Status: UNKNOWN